Inventor · disambiguated record
Terrence Joseph Connolly
Also filed as: CONNOLLY TERRENCE J · CONNOLLY TERRENCE JOSEPH
16 granted patents·14 pending applications·59 citations·filing 2003–2024
90Inventor score
Files withK36 THERAPEUTICS INC12CELGENE CORP10ROCHE PALO ALTO LLC4SIGNAL PHARM LLC2CONNOLLY TERRENCE J1
Top patents by PatentIndex Score
30 records- 0190US9126906B2Asymmetric synthetic processes for the preparation of aminosulfone compoundsCELGENE CORP·Filed 2013·Granted Sep 8, 2015·5 cites·43 claims
- 0289US10252981B2Methods of synthesis of (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful thereinCELGENE CORP·Filed 2016·Granted Apr 9, 2019·3 cites·16 claims
- 0388US9403829B2Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their useSIGNAL PHARM LLC·Filed 2012·Granted Aug 2, 2016·13 cites·29 claims
- 0487US6864244B2Anhydrous crystalline 1-[4(S)-azido-2(S),3(R)-dihydroxy-4-(hydroxymethyl)-1(R)-cyclopentyl]cytosine hemisulfate as useful as an antiviral agentROCHE PALO ALTO LLC·Filed 2003·Granted Mar 8, 2005·27 cites·20 claims
- 0584US8981117B2Processes for the preparation of isoindole compounds and isotopologues thereofCELGENE CORP·Filed 2013·Granted Mar 17, 2015·4 cites·25 claims
- 0682US9434689B2Processes for the preparation of isoindole compounds and isotopologues thereofCELGENE CORP·Filed 2015·Granted Sep 6, 2016·3 cites·18 claims
- 0781US11780801B2Methods of synthesis of (1R,2R,5R)-5-amino-2-methyl-cyclohexanol hydrochloride and intermediates useful thereinCELGENE CORP·Filed 2021·Granted Oct 10, 2023·0 cites·12 claims
- 0876US9187417B2Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamineCELGENE CORP·Filed 2013·Granted Nov 17, 2015·3 cites·30 claims
- 0975US11192847B2Methods of synthesis of (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful thereinCELGENE CORP·Filed 2020·Granted Dec 7, 2021·0 cites·3 claims
- 1073US10774033B2Methods of synthesis of (1R, 2R, 5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful thereinCELGENE CORP·Filed 2019·Granted Sep 15, 2020·0 cites·3 claims
- 1166US12492203B2Deuterium-enriched piperidinyl-methyl-purine amines and related compounds and their use in treating diseases and conditionsK36 THERAPEUTICS INC·Filed 2024·Granted Dec 9, 2025·0 cites·20 claims
- 1261US7244738B2Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonistsROCHE PALO ALTO LLC·Filed 2004·Granted Jul 17, 2007·1 cites·11 claims
- 1358US2025163067A1Nucleobase-substituted piperidinyl-pyridines and related compounds and their use in treating diseases and conditionsK36 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1458US2025171454A1Heterobifunctional pyridinylmethyl aminopurine and related compounds and their use in nsd2 degradation and treating medical conditionsK36 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1558US2025171445A1Deuterium-enriched piperidinyl-methyl-purine amine salts, crystalline forms, and their use in treating medical diseases and conditionsK36 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1657US2024417401A1Heterobicyclic-methylpurine pyridines and related compounds and their use in treating diseases and conditionsK36 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1757US2025011329A1Substituted piperidinyl-methylpurine pyridines and related compounds and their use in treating diseases and conditionsK36 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1856US9688623B2Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamineCELGENE CORP·Filed 2017·Granted Jun 27, 2017·0 cites·9 claims
- 1956US2024415864A1Carbohydrate-functionalized piperidinyl-methylpurine pyridines and related compounds and their use in treating diseases and conditionsK36 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2054US2024207192A1Pharmaceutical compositions containing a piperidinyl-methyl-purine amine and their use in treating diseases and conditionsK36 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2154US2025206740A1Piperidinyl-methylpurine pyrimidines and related compounds and their use in treating diseases and conditionsK36 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2254US2025361235A1Piperidinyl-methylpurine benzenes and related compounds and their use in treating diseases and conditionsK36 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2353US7598399B2Methods for synthesis of 3-amino-1-arylpropyl indolesROCHE PALO ALTO LLC·Filed 2006·Granted Oct 6, 2009·0 cites·15 claims
- 2452US9586897B2Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamineCELGENE CORP·Filed 2015·Granted Mar 7, 2017·0 cites·2 claims
- 2552US2007265446A1Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonistsCONNOLLY TERRENCE J·Filed 2007·Application pending·0 cites
- 2646US2005038240A1Processes for preparing 4'-azido-nucleoside derivativesROCHE PALO ALTO LLC·Filed 2004·Application pending·0 cites
- 2745US2009023903A1Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamidesWYETH CORP·Filed 2008·Application pending·0 cites
- 2844US2025326752A1Piperidinyl-methyl-purine amine salts, crystalline forms, and their use in treating medical diseases and conditionsK36 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2944US2024002385A1Piperidinyl-methyl-purine amine d-tartaric acid salts, crystalline forms, and their use in treating medical diseases and conditionsK36 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3042US9434735B2Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2015·Granted Sep 6, 2016·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →